• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    NeurogesX, Inc. (NGSX)

    -Other OTC
    0.00 Down 0.00(38.00%) 1:48PM EST
    Add to Portfolio
    Prev Close:0.01
    Open:0.01
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:1.52
    Next Earnings Date:N/A
    Day's Range:0.00 - 0.01
    52wk Range:0.00 - 0.02
    Volume:51,786
    Avg Vol (3m):52,166
    Market Cap:103.58K
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for NGSX at this time.

    Comparison

    Symbol% ChgMkt Cap
    NGSXDown 38.00%103.58K
    LLYDown 0.07%77.44B
    ENDPUp 2.37%11.22B
    PFEDown 0.09%201.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeurogesX, Inc., a biopharmaceutical company, engages in developing and commercializing pain management therapies. The company offers Qutenza for the management of neuropathic pain associated with postherpetic neuralgia, and for the treatment of p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback